CH/π hydrogen bonds play a role in ligand recognition and equilibrium between active and inactive states of the β2 adrenergic receptor: an ab initio fragment molecular orbital (FMO) study.

We examined CH/π hydrogen bonds using an ab initio fragment molecular orbital (FMO) method, combined with the CHPI program, to evaluate complexes of active (bound with agonist 1) and inactive (bound with inverse agonist 2) β2 adrenergic receptor (β(2)AR) states. In both states, we found that CH/π hydrogen bonds were present. Subtle changes in the binding pocket between the active and inactive states of β(2)AR were observed. Comparison of the CH/π networks in both states suggests that the networks differ at the β(2)AR core. Recombination of the CH/π hydrogen bonds occurred during conversion between the two states. We suggest that CH/π hydrogen bonds play a key role in ligand recognition and conversion between the active and inactive states.

[1]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[2]  G. Tóth,et al.  The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance. , 2007, Current pharmaceutical design.

[3]  Masami Uebayasi,et al.  Pair interaction molecular orbital method: an approximate computational method for molecular interactions , 1999 .

[4]  L. Pardo,et al.  The importance of solvation in the design of ligands targeting membrane proteins , 2011 .

[5]  M. Mortrud,et al.  The G protein-coupled receptor repertoires of human and mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Nishio,et al.  CH/pi interactions as demonstrated in the crystal structure of guanine-nucleotide binding proteins, Src homology-2 domains and human growth hormone in complex with their specific ligands. , 1998, Bioorganic & medicinal chemistry.

[7]  David L Bryce,et al.  Direct detection of CH/pi interactions in proteins. , 2010, Nature chemistry.

[8]  Gebhard F. X. Schertler,et al.  Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.

[9]  E. ter Haar,et al.  CH...O and CH...N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitor. , 2005, Journal of medicinal chemistry.

[10]  Kaori Fukuzawa,et al.  Possibility of mutation prediction of influenza hemagglutinin by combination of hemadsorption experiment and quantum chemical calculation for antibody binding. , 2009, The journal of physical chemistry. B.

[11]  Asuka Fujii,et al.  Magnitude and nature of interactions in benzene-X (X=ethylene and acetylene) in the gas phase: significantly different CH/pi interaction of acetylene as compared with those of ethylene and methane. , 2007, The journal of physical chemistry. A.

[12]  J Sühnel,et al.  More Hydrogen Bonds for the (structural) Biologist , 2022 .

[13]  R. Stevens,et al.  Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.

[14]  Jessica Sallander,et al.  Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation. , 2010, Journal of medicinal chemistry.

[15]  M. Nishio,et al.  CH/pi interactions in the crystal structure of TATA-box binding protein/DNA complexes. , 2000, Bioorganic & medicinal chemistry.

[16]  Brian K. Shoichet,et al.  Rapid Context-Dependent Ligand Desolvation in Molecular Docking , 2010, J. Chem. Inf. Model..

[17]  S. Rasmussen,et al.  Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.

[18]  J. Bertran,et al.  CH/pi interactions in DNA and proteins. A theoretical study. , 2007, The journal of physical chemistry. B.

[19]  H. Iwamura,et al.  Intramolecular Interaction between Hydroxyl Group and π-Electrons. VI. Electronic Effect on the Interaction in ω-Arylalkanols , 1959 .

[20]  Andreas Evers,et al.  Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening. , 2009, Journal of medicinal chemistry.

[21]  S. Sakaki,et al.  Structures and binding energies of benzene-methane and benzene-benzene complexes : an ab initio SCF/MP2 study , 1993 .

[22]  M. Nishio,et al.  CH/π Interactions Implicated in the Crystal Structure of Transition Metal Compounds − A Database Study , 2002 .

[23]  Osamu Takahashi,et al.  Relevance of weak hydrogen bonds in the conformation of organic compounds and bioconjugates: evidence from recent experimental data and high-level ab initio MO calculations. , 2010, Chemical reviews.

[24]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[25]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[26]  M. Nishio,et al.  CH/π Interaction in the Crystal Structure of Organic Compounds. A Database Study , 1998 .

[27]  Yutaka Akiyama,et al.  Fragment molecular orbital method: application to polypeptides , 2000 .

[28]  M. Nishio,et al.  CH/π hydrogen bonds as evidenced in the substrate specificity of acetylcholine esterase , 2005 .

[29]  H Takahashi,et al.  CH/π Interactions as Demonstrated in the Crystal Structure of Host/Guest Compounds. A Database Study , 2000 .

[30]  M. Burghammer,et al.  Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.

[31]  M. Nishio,et al.  interaction in the conformation of organic compounds. A database study , 1999 .

[32]  M. W. Wong,et al.  Saturated hydrocarbon-benzene complexes: theoretical study of cooperative CH/pi interactions. , 2006, The journal of physical chemistry. A.

[33]  Mary E Abood,et al.  An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region. , 2003, Journal of medicinal chemistry.

[34]  Jonathan A. Javitch,et al.  Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist , 2010, Science.

[35]  Takeshi Ishikawa,et al.  Theoretical study of the prion protein based on the fragment molecular orbital method , 2009, J. Comput. Chem..

[36]  Tomonaga Ozawa,et al.  The importance of CH/pi hydrogen bonds in rational drug design: An ab initio fragment molecular orbital study to leukocyte-specific protein tyrosine (LCK) kinase. , 2008, Bioorganic & medicinal chemistry.

[37]  M. Kataoka,et al.  A Single CH/π Weak Hydrogen Bond Governs Stability and the Photocycle of the Photoactive Yellow Protein , 2006 .

[38]  Kazumasa Honda,et al.  The Magnitude of the CH/π Interaction between Benzene and Some Model Hydrocarbons , 2000 .

[39]  Kaori Fukuzawa,et al.  Molecular interactions between estrogen receptor and its ligand studied by the ab initio fragment molecular orbital method. , 2006, The journal of physical chemistry. B.

[40]  Kosuke Okazaki,et al.  CH/π hydrogen bonds determine the selectivity of the Src homology 2 domain to tyrosine phosphotyrosyl peptides: An ab initio fragment molecular orbital study , 2008, J. Comput. Chem..

[41]  R. Riek,et al.  Mutation of a single TMVI residue, Phe(282), in the beta(2)-adrenergic receptor results in structurally distinct activated receptor conformations. , 2002, Biochemistry.

[42]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[43]  T. Nakano,et al.  An application of fragment interaction analysis based on local MP2 , 2008 .

[44]  Cheng Zhang,et al.  Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.

[45]  M. Nishio,et al.  The CH/π hydrogen bond in chemistry. Conformation, supramolecules, optical resolution and interactions involving carbohydrates. , 2011, Physical chemistry chemical physics : PCCP.

[46]  D. Gloriam,et al.  Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design. , 2009, Journal of medicinal chemistry.

[47]  Kazuo Kitaura,et al.  Molecular recognition mechanism of FK506 binding protein: An all‐electron fragment molecular orbital study , 2007, Proteins.

[48]  Kazuo Kitaura,et al.  The Fragment Molecular Orbital Method: Practical Applications to Large Molecular Systems , 2009 .

[49]  Christopher G. Tate,et al.  The structural basis for agonist and partial agonist action on a β1-adrenergic receptor , 2010, Nature.

[50]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[51]  M. Nishio,et al.  CH/π hydrogen bonds in organic and organometallic chemistry , 2009 .

[52]  Gerhard Hessler,et al.  Drug Design Strategies for Targeting G‐Protein‐Coupled Receptors , 2002, Chembiochem : a European journal of chemical biology.